We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
26
TJX Companies
TJX
$175B
$1.98M 0.77%
+18,003
New +$1.81M
EOG icon
27
EOG Resources
EOG
$74.6B
$1.98M 0.77%
15,698
+7,005
+81% +$899K
JNJ icon
28
Johnson & Johnson
JNJ
$631B
$1.96M 0.76%
13,383
+772
+6% +$115K
NEE icon
29
NextEra Energy
NEE
$177B
$1.95M 0.76%
27,487
-7,208
-21% -$511K
PNC icon
30
PNC Financial Services
PNC
$100B
$1.9M 0.74%
12,229
-733
-6% -$114K
COP icon
31
ConocoPhillips
COP
$148B
$1.88M 0.73%
16,427
+7,490
+84% +$910K
AXP icon
32
American Express
AXP
$229B
$1.84M 0.72%
7,956
-430
-5% -$99.6K
GOOGL icon
33
Alphabet (Google) Class A
GOOGL
$4.37T
$1.79M 0.69%
9,823
+5,807
+145% +$979K
BDX icon
34
Becton Dickinson
BDX
$48.9B
$1.77M 0.69%
7,586
-277
-4% -$65.3K
MDT icon
35
Medtronic
MDT
$114B
$1.75M 0.68%
22,285
-931
-4% -$76.3K
QCOM icon
36
Qualcomm
QCOM
$170B
$1.2M 0.47%
6,045
+1,492
+33% +$282K
AMAT icon
37
Applied Materials
AMAT
$415B
$1.15M 0.45%
4,880
-3,220
-40% -$691K
TEL icon
38
TE Connectivity
TEL
$62B
$1.15M 0.45%
7,627
-6,277
-45% -$921K
META icon
39
Meta Platforms (Facebook)
META
$1.52T
$1.12M 0.44%
2,229
-1,448
-39% -$704K
HON icon
40
Honeywell
HON
$77B
$1.12M 0.43%
+5,562
New +$1.06M
LRCX icon
41
Lam Research
LRCX
$383B
$1.11M 0.43%
10,420
+3,090
+42% +$296K
CMCSA icon
42
Comcast
CMCSA
$89.4B
$1.11M 0.43%
28,300
-17,176
-38% -$672K
UNH icon
43
UnitedHealth
UNH
$371B
$1.1M 0.43%
2,156
-1,682
-44% -$824K
V icon
44
Visa
V
$675B
$1.04M 0.4%
3,960
-3,285
-45% -$900K
PPG icon
45
PPG Industries
PPG
$25.7B
$1.04M 0.4%
8,252
-5,456
-40% -$723K
ADI icon
46
Analog Devices
ADI
$187B
$1.03M 0.4%
4,509
-231
-5% -$49.3K
TXRH icon
47
Texas Roadhouse
TXRH
$13.6B
$1.01M 0.39%
5,896
-471
-7% -$76.8K
PEP icon
48
PepsiCo
PEP
$188B
$1.01M 0.39%
6,096
-4,483
-42% -$774K
MDLZ icon
49
Mondelez International
MDLZ
$78.5B
$1M 0.39%
15,352
-36,767
-71% -$2.52M
MCD icon
50
McDonald's
MCD
$194B
$979K 0.38%
3,841
-9,561
-71% -$2.54M

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.